| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,899,050 | 9,250,443 | 7,449,166 | | Cost of Revenue | 2,697,935 | 5,570,715 | 4,324,652 | | | Gross Profit | 5,201,115 | 3,679,728 | 3,124,514 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,111,214 | 23,650 |
-
| | Non Recurring | 48,280 | 20,796 | 58,179 | | Others | 1,442,663 | 1,697,403 | 1,395,528 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,598,958 | 1,937,879 | 1,670,807 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (18,003) | (11,927) | 51,915 | | Earnings Before Interest And Taxes | 1,615,324 | 2,000,674 | 1,709,850 | | Interest Expense | 390,329 | 473,511 | 438,146 | | Income Before Tax | 1,224,995 | 1,527,163 | 1,271,704 | | Income Tax Expense | 322,410 | 167,589 | 301,193 | | Minority Interest | (2,455) | (6,728) | (7,294) | | | | Net Income From Continuing Ops | 865,761 | 1,278,124 | 976,089 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 865,761 | 1,278,124 | 976,089 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $865,761 | $1,278,124 | $976,089 |
|
0.08% Nasdaq 
0.41%
Income Statement
